Intestinal Adsorbent and Breath Gas Levels

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 13, 2019

Primary Completion Date

October 1, 2020

Study Completion Date

December 1, 2020

Conditions
Gastroesophageal RefluxSmall Intestinal Bacterial Overgrowth
Interventions
DEVICE

Intestinal adsorbent

Participants will consume the 15ml of the intestinal adsorbent (3.5 g Silicon dioxide in 100 ml Silicic acid gel, Preservatives: Sorbic acid (E 200), Sodium benzoate (E 211). ) three times daily for 10 days. There are no known side effects of the medical device. The product is a class IIa medical device under the European council directive and the product will be used within it's current indications.

Trial Locations (1)

M2 4NG

The Functional Gut Clinic, Manchester

All Listed Sponsors
lead

Dr Anthony Hobson

OTHER

NCT04492839 - Intestinal Adsorbent and Breath Gas Levels | Biotech Hunter | Biotech Hunter